Figure 5.
Peak antibody responses to angiopoeitin-2 after vaccination among patients transplanted with active disease (≥5% marrow blasts) vs no active disease (<5% marrow blasts).
Peak antibody responses to angiopoeitin-2 after vaccination among patients transplanted with active disease (≥5% marrow blasts) vs no active disease (<5% marrow blasts).
